» Articles » PMID: 9745876

The Fanconi Syndrome of Cystinosis: Insights into the Pathophysiology

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 1998 Sep 24
PMID 9745876
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Cystinosis is a lysosomal storage disease which is the most-common inherited cause of the Fanconi syndrome. Insights into the pathophysiology of the proximal tubular defect have come from in vitro studies of the cystine-loaded tubule. Proximal tubules loaded with cystine have a generalized proximal tubule transport defect characteristic of the Fanconi syndrome. The decrease in proximal tubular transport with cystine loading is not due to an increase in paracellular permeability with backflux of solute transport from the blood to the tubular lumen, but due to a decrease in active transport. The Na-K-ATPase activity is intact under Vmax conditions in cystine-loaded tubules; however, the production of ATP is severely compromised. The cystine-loaded tubule has a lower intracellular phosphate concentration than that of control tubules. This low intracellular phosphate concentration in cystine-loaded tubules likely plays a critical role in the decrease in intracellular ATP. Preservation of intracellular phosphate at control levels prevents the decrease in intracellular ATP and the proximal tubule respiratory dysfunction with cystine loading. The clinical significance and future directions for investigation are discussed.

Citing Articles

Deletion Variant in Basenji Dogs with Fanconi Syndrome.

Farias F, Mhlanga-Mutangadura T, Guo J, Hansen L, Johnson G, Katz M Genes (Basel). 2024; 15(11).

PMID: 39596669 PMC: 11593659. DOI: 10.3390/genes15111469.


When Two Syndromes Collide: Managing Fanconi and Refeeding Syndrome in a Single Patient.

Gallegos Koyner F, Barrera N, Subedi P, Shrestha K, Cerrud-Rodriguez R Cureus. 2024; 16(1):e52169.

PMID: 38344551 PMC: 10859126. DOI: 10.7759/cureus.52169.


Role of transporters in regulating mammalian intracellular inorganic phosphate.

Jennings M Front Pharmacol. 2023; 14:1163442.

PMID: 37063296 PMC: 10097972. DOI: 10.3389/fphar.2023.1163442.


A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers.

Berends C, Pagan L, van Esdonk M, Klarenbeek N, Bergmann K, Moerland M Pharmacol Res Perspect. 2021; 9(2):e00739.

PMID: 33764642 PMC: 7992283. DOI: 10.1002/prp2.739.


Proximal renal tubular acidosis with and without Fanconi syndrome.

Kashoor I, Batlle D Kidney Res Clin Pract. 2019; 38(3):267-281.

PMID: 31474092 PMC: 6727890. DOI: 10.23876/j.krcp.19.056.